Skip to main content
. 2019 Sep 17;5(9):e02349. doi: 10.1016/j.heliyon.2019.e02349

Table 2.

The antibiotic susceptibility testing results of 100 K. pneumoniae isolates based on CLSI 2015.

Antibiotic Total K. pneumoniae No. (%)
ESBL-producing K. pneumoniae No. (%)
Resistant Intermediate Sensitive Resistant Intermediate Sensitive
Nitrofurantoin 75 (75%) 5 (5%) 20 (20%) 38 (76%) 2 (4%) 10 (20%)
Nalidixic acid 55 (55%) 5 (5%) 40 (40%) 25 (50%) 2 (4%) 23 (46%)
Cefepime 50 (50%) 5 (5%) 45 (45%) 29 (58%) 1 (2%) 20 (40%)
Gentamicin 30 (30%) 10 (10%) 60 (60%) 11 (22%) 3 (6%) 36 (72%)
Ceftazidime 55 (55%) 5 (5%) 40 (40%) 37 (74%) 3 (6%) 10 (20%)
Cefotaxime 40 (40%) 15 (15%) 45 (45%) 33 (66%) 8 (16%) 9 (18%)
Ciprofloxacin 60 (60%) 10 (10%) 30 (30%) 35 (70%) 4 (8%) 11 (22%)
Cefteriaxon 40 (40%) 15 (15%) 45 (45%) 32 (64%) 8 (16%) 10 (20%)
Trimethoprim/Sulfamethoxazole 65 (65%) 5 (5%) 30 (30%) 39 (78%) 0 (0%) 11 (22%)
Norfloxacin 65 (65%) 10 (10%) 25 (25%) 31 (62%) 4 (8%) 15 (30%)
Imipenem 15 (15%) 5 (5%) 80 (80%) 8 (16%) 0 (0%) 42 (84%)
Amikacin 50 (50%) 10 (10%) 40 (40%) 29 (58%) 6 (12%) 15 (30%)